- Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients
De Francia S, Ariaudo A, Pirro E, dAvolio A, Piccione FM, Simiele M, Fava C, Saglio G, Di Carlo F
- Pharmacokinetic analysis of mephedrone and methylone after intravenous and oral administration in rats.
Lopez Arnau R, Martinez Clemente JM, Carbo M, Pubill D, Camarasa J, Escubedo E
- Pharmacokinetic and pharmacodynamic of dexamethasone - butyrate loaded solid lipid nanoparticles
Imbalzano E, Muntoni E, Serpe L, Foglietta F, Canaparo R, Gasco P, Zara GP
- Pharmacokinetic diversity of two modified-release diltiazem formulations
Bogiel M, Duda J, Pawlowska M, Sieradzki E
- Pharmacokinetic interaction between linezolid and grapefruit juice in healthy volunteers
Cuciureanu M, Cuciureanu R, Munteanu D, Radulescu FS, Diaconu C, Vlase L
- Pharmacokinetic parameters of ss-hydroxyacid simvastatin in experimental hypothyroidism
Yakusheva EN, Popova NM
- Pharmacokinetics and bioequivalence evaluation of two product of digoxin 0.25mg tablets after a single dose administration in healthy volunteers: an open, crossover randomised bioequivalence clinical trial
Ochoa D, Ronan M, Moreno I, Sanchez Rojas S, Abad Santos F
- Pharmacological characterization of the mechanism underlying the inflammatory response in dermonecrosis induced by Cerastes cerastes venom
Oussedik Oumehdi H, Laraba Djebari F
- Pharmacological characterization of the new selective sigma-1 receptor (σ 1 R) antagonist S1RA for the treatment of neuropathic pain
Merlos M, Sanchez Arroyos R, Portillo Salido E, Romero L, Muro A, Burgueno J, Maldonado R, Baeyens JM, Zamanillo D, Vela JM
- Pharmacological concentrations of mitoxantrone are able to activate caspases and dually modify glutathione pathways in HL-1 cardiomyocytes
Costa VM, Capela JP, Bastos ML, Duarte JA, Remiao F, Carvalho F
